Jong-Hyun Choi
Director Ejecutivo en NC& CO.,LTD .
Fortuna: 228 240 $ al 30/04/2024
Perfil
Jong-Hyun Choi is currently the Chief Executive Officer & Director at NC & Co., Ltd.
He is also a Director at Biobud Ltd., Nconnect Corp., Vadas Corp., and 2ip, Inc. (KR).
Mr. Choi completed his undergraduate degree at Sogang University.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
NEXTCHIP CO. LTD.
0.16% | 29/04/2024 | 28 065 ( 0.16% ) | 228 240 $ | 30/04/2024 |
Cargos activos de Jong-Hyun Choi
| Empresas | Cargo | Inicio |
|---|---|---|
| NC& CO.,LTD | Director Ejecutivo | - |
Biobud Ltd.
 Biobud Ltd. Medical SpecialtiesHealth Technology Biobud Ltd. engages in the development of biopharmaceuticals for cardiovascular prevention, diagnosis and treatment. The company was founded on March 28, 2000, and is headquartered in Seongnam, South Korea. | Director/Miembro de la Junta | - |
| Nconnect Corp. | Director/Miembro de la Junta | - |
| Vadas Corp. | Director/Miembro de la Junta | - |
| 2ip, Inc. (KR) | Director/Miembro de la Junta | - |
Formación de Jong-Hyun Choi.
| Sogang University | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| NC& CO.,LTD | Electronic Technology |
| Empresas privadas | 4 |
|---|---|
Biobud Ltd.
Biobud Ltd. Medical SpecialtiesHealth Technology Biobud Ltd. engages in the development of biopharmaceuticals for cardiovascular prevention, diagnosis and treatment. The company was founded on March 28, 2000, and is headquartered in Seongnam, South Korea. | Health Technology |
| Nconnect Corp. | |
| Vadas Corp. | |
| 2ip, Inc. (KR) |
- Bolsa de valores
- Insiders
- Jong-Hyun Choi
